Skip to search.
 FTSE 100 Down 1.00%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
355.00 Up 8.25(2.38%) 9 Feb 17:33
Prev Close:355.00
Open:358.00
Bid:N/A
Ask:450.00
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:347.82 - 360.00
52wk Range:249.25 - 414.45
Volume:312,653
Avg Vol (3m):168,785
Market Cap:371.76m
P/E (ttm):22.90
EPS (ttm):15.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.18
P/S (ttm):463.89
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :21.07
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products. The company’s inhalation products include flutiform, a multi-dose pressurized metered dose inhaler for the treatment of bronchial asthma; Anoro Ellipta and Incruse... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback